<!DOCTYPE html><html>
<head>
<style type="text/css">
#table-icm {
	width: 100%;
  border-collapse:collapse;
  font-family: arial;
  font-size:14px;
}
#table-icm th {
  background-color: #AAA;
  color: white;
  border:1px solid gray;
  padding: 5px;
}
#table-icm td {
  border:1px solid gray;
  padding: 5px;
}
#table-icm tr:nth-child(even) {background: #EEE}
#table-icm tr:nth-child(odd) {background: #FFF}
</style>
<script src="http://www.molsoft.com/sorttable.js"></script>
<script src="http://www.molsoft.com/lib/moledit.js"></script>
<script>function onLoadMoledit(){

}</script></head>
<body>
<table id="table-icm"  class="sortable">
<thead>
<th>index</th><th>Protein_Name</th><th>up_name</th><th>Gene_Name_Synonym</th><th>Uniprot_ID</th><th>ligand_desolvation</th><th>most_potent_compound_in_PDB_nM</th>
</thead>
<tr>
<td align="right" >1</td><td>Adenosine receptor A2a</td><td>AA2AR</td><td>ADORA2</td><td>P29274</td><td align="right" >76.55</td><td align="right" >0.248</td>
</tr>
<tr>
<td align="right" >2</td><td>Beta-2 adrenergic receptor (Beta-2 adrenoreceptor) (Beta-2 adrenoceptor)</td><td>ADRB2</td><td>ADRB2R B2AR</td><td>P07550</td><td align="right" >97.3</td><td align="right" >0.084</td>
</tr>
<tr>
<td align="right" >3</td><td>Kappa-type opioid receptor (K-OR-1) (KOR-1)</td><td>OPRK</td><td>OPRK</td><td>P41145</td><td align="right" >90.43</td><td align="right" >0.32</td>
</tr>
<tr>
<td align="right" >4</td><td>Nociceptin receptor (Kappa-type 3 opioid receptor) (KOR-3) (Orphanin FQ receptor)</td><td>OPRX</td><td>OOR ORL1</td><td>P41146</td><td align="right" >85.2</td><td align="right" >0.27</td>
</tr>
<tr>
<td align="right" >5</td><td>Type-1 angiotensin II receptor (AT1AR) (AT1BR) (Angiotensin II type-1 receptor) (AT1)</td><td>AGTR1</td><td>AGTR1A AGTR1B AT2R1 AT2R1B</td><td>P30556</td><td align="right" >80.69</td><td align="right" >2.9</td>
</tr>
<tr>
<td align="right" >6</td><td>Orexin receptor type 1 (Ox-1-R) (Ox1-R) (Ox1R) (Hypocretin receptor type 1)</td><td>OX1R</td><td></td><td>O43613</td><td align="right" >87.75</td><td align="right" >1.1</td>
</tr>
<tr>
<td align="right" >7</td><td>C-C chemokine receptor type 9 (C-C CKR-9) (CC-CKR-9) (CCR-9) (G-protein coupled receptor 28) (GPR-9-6) (CD antigen CDw199)</td><td>CCR9</td><td>GPR28</td><td>P51686</td><td align="right" >98.69</td><td align="right" >0.11</td>
</tr>
<tr>
<td align="right" >8</td><td>Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2]</td><td>PAR2</td><td>GPR11 PAR2</td><td>P55085</td><td align="right" >99.39</td><td align="right" >344</td>
</tr>
<tr>
<td align="right" >9</td><td>5-hydroxytryptamine receptor 2B (5-HT-2B) (5-HT2B) (Serotonin receptor 2B)</td><td>5HT2B</td><td></td><td>P41595</td><td align="right" >92.59</td><td align="right" >0.91</td>
</tr>

</table>
</body>
</html>
